Guglielmo Rosignoli
Overview
Explore the profile of Guglielmo Rosignoli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sitnikova S, Munnings-Tomes S, Galvani E, Kentner S, Mulgrew K, Rands C, et al.
J Immunother Cancer
. 2021 Jun;
9(6).
PMID: 34145033
Background: Immuno-oncology therapies are now part of the standard of care for cancer in many indications. However, durable objective responses remain limited to a subset of patients. As such, there...
2.
Patel Y, Brown A, Zhu J, Rosignoli G, Gibson S, Hatton D, et al.
ACS Synth Biol
. 2021 May;
10(5):1155-1165.
PMID: 33939428
To successfully engineer mammalian cells for a desired purpose, multiple recombinant genes are required to be coexpressed at a specific and optimal ratio. In this study, we hypothesized that synthetic...
3.
Watson J, Sanders P, Dunmore R, Rosignoli G, Jule Y, Rawlins E, et al.
Sci Rep
. 2020 Jun;
10(1):10490.
PMID: 32591591
Tissue stem cell exhaustion is a key hallmark of aging, and in this study, we characterised its manifestation in the distal lung. We compared the lungs of 3- and 22-month...
4.
Cartwright J, Arnall C, Patel Y, Barber N, Lovelady C, Rosignoli G, et al.
J Biotechnol
. 2020 Mar;
312:11-22.
PMID: 32114154
An increasing number of engineered therapeutic recombinant proteins with unpredictable manufacturability are currently filling industrial cell line development pipelines. These proteins can be "difficult-to-express" (DTE) in that production of a...
5.
Pekle E, Smith A, Rosignoli G, Sellick C, Smales C, Pearce C
Biotechnol J
. 2019 Mar;
14(7):e1800675.
PMID: 30925020
Biopharmaceutical manufacturing using Chinese hamster ovary (CHO) cells requires the generation of high-producing clonal cell lines. During cell line development, cell cloning using fluorescence-activated cell sorting (FACS) has the potential...
6.
Camelo A, Rosignoli G, Ohne Y, Stewart R, Overed-Sayer C, Sleeman M, et al.
Blood Adv
. 2018 Jan;
1(10):577-589.
PMID: 29296700
Innate lymphoid cells (ILCs) represent a distinct branch of the lymphoid lineage composed of 3 major subpopulations: ILC1, ILC2, and ILC3. ILCs are mainly described as tissue-resident cells but can...
7.
Carlotti E, Wrench D, Rosignoli G, Marzec J, Sangaralingam A, Hazanov L, et al.
PLoS One
. 2015 Sep;
10(9):e0134833.
PMID: 26325507
Understanding the dynamics of evolution of Follicular Lymphoma (FL) clones during disease progression is important for monitoring and targeting this tumor effectively. Genetic profiling of serial FL biopsies and examples...
8.
Miraki-Moud F, Anjos-Afonso F, Hodby K, Griessinger E, Rosignoli G, Lillington D, et al.
Proc Natl Acad Sci U S A
. 2013 Aug;
110(33):13576-81.
PMID: 23901108
Acute myeloid leukemia (AML) induces bone marrow (BM) failure in patients, predisposing them to life-threatening infections and bleeding. The mechanism by which AML mediates this complication is unknown but one...
9.
Dalli J, Rosignoli G, Hayhoe R, Edelman A, Perretti M
Am J Pathol
. 2010 May;
177(1):176-86.
PMID: 20489160
Cystic fibrosis (CF), a disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, is characterized by chronic bacterial infections and inflammation in the lung. Having previously shown...
10.
Gudmundsdotter L, Bostrom A, Burton C, Rosignoli G, Sandstrom E, Hejdeman B, et al.
Vaccine
. 2008 May;
26(40):5107-10.
PMID: 18455841
Objective: To evaluate functional potential and phenotypic markers in HIV-1-infected patients immunized with HIV-1 rgp160. Methods: We assessed changes in T-cell phenotype and immune function in 12 HIV-1-infected individuals that...